Healthium’s current product portfolio focuses on advanced surgery, urology and arthroscopy products covering 52,000 stock-keeping units
Healthium Medtech, a global medtech company focussed on products used in surgical, post-surgical and chronic care, announced the launch of TRUSHIELD NXT surgical wound dressing, adding to its portfolio of patented products in the wound care and infection prevention segments. In addition to wound care, Healthium’s current product portfolio focuses on advanced surgery, urology and arthroscopy products covering 52,000 stock-keeping units.
The announcement comes after Healthium acquires CareNow Medical last month. As of July 31, 2021, the company has 21 patents in India and 11 patents in the United States, and a further 22 and 6 patent applications pending approval in India and US, respectively. With the acquisition of CareNow, the company has acquired an additional portfolio of one patent each in India, the US and Europe and one patent application pending approval in India.
TRUSHIELD NXT combines the advantages of a 3D hydrocellular substrate and patented infection prevention technology to offer a complete wound care system that provides 360-degree wound protection. It provides exudate and moisture management while remaining waterproof. Its patented technology continuously inhibits pathogen growth with a unique non-leaching, non-depleting kill mechanism. It has patents in the US, Europe and India.
Anish Bafna, CEO and MD, Healthium Medtech, said, “We are excited to add TRUSHIELD NXT to strengthen our wound care and post-surgical care portfolio. Aligned to our vision “Access to precision medtech for every patient, globally,” TRUSHIELD NXT is manufactured to high-quality standards at our US FDA registered plant. With our sales network reaching 90 per cent of districts in India with secondary healthcare facilities catering to 40,000 surgeons across 18000 hospitals, we look to offering wider choices to our customers and delivering better standards in patient care, with innovative and quality products.”
Dr Ashok Moharana, Chief Medical Officer, Healthium Medtech said, “A successful surgery is complemented by a well-healed wound. TRUSHIELD NXT surgical wound dressing enables healing through exudate and moisture management ability while providing infection control with a patented technology that continuously inhibits the growth of pathogen ( 99.99 per cent kill rate against a broad spectrum of the pathogen). The dressing is waterproof and does not adhere to the wound, for a trauma-less removal. We believe that with this new technology and our access, we will be able to benefit patients globally.”
